Avexitide: all 36 studies that test it

Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.

• Islet Function in Gestational DiabetesRecruitingNCT07806695Phase 1
• The Effect of rs7903146 Genotype on Islet GLP-1 Production in HumansNot yet recruitingNCT06972407Phase 2
• The Role of Islet GLP-1 in the Pathogenesis of PrediabetesRecruitingNCT06967558Phase 2
• The Effects of Bariatric Surgeries on Glucose MetabolismRecruitingNCT02823665Early Phase 1
• Glucagon-like Peptide 1, Glucose Metabolism and Gastric BypassRecruitingNCT01803451Early Phase 1
• Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass SurgeryRecruitingNCT00992901Early Phase 1
• Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic HypoglycemiaCompletedNCT04652479Phase 2Results posted
• Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 DiabetesCompletedNCT04466618Phase 3Results posted
• A Dose-response Study Examining the Contribution of GLP-1 Receptor Signaling to Glucagon-stimulated Insulin SecretionCompletedNCT04459338Phase 3Results posted
• Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric HypoglycemiaCompletedNCT03373435Phase 2Results posted
• Regulation of Insulin Secretion by the GLP-1 ReceptorTerminatedNCT02844907Phase 4Results posted
• Exendin-9,39 and Satiety After Bariatric SurgeryCompletedNCT02779075Not applicableResults posted
• Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric HypoglycemiaCompletedNCT02771574Phase 2Results posted
• The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 DiabetesCompletedNCT02762708Phase 2Results posted
• Gastrointestinal Sensorimotor Dysfunctions in Diabetes MellitusCompletedNCT02170870Phase 2Results posted
• Effect of DPP4 Inhibition on Growth Hormone SecretionCompletedNCT01701973Phase 4Results posted
• Role of Glucagon-Like Peptide-1 in Postprandial HypoglycemiaCompletedNCT01162499Not applicableResults posted
• Effect of Exendin-(9-39) on Fasting Adaptation and Protein SensitivityCompletedNCT00897676Phase 1/2Results posted
• Effect of Exendin (9-39) on Glucose Requirements to Maintain EuglycemiaTerminatedNCT00835328Phase 1/2Results posted
• Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital HyperinsulinismCompletedNCT00571324Phase 1/2Results posted
• The Effect of Endogenous GLP-1 on Glucagon Secretion in Type 1 DiabetesCompletedNCT07373236Not applicable
• Avexitide for Treatment of Post-Bariatric HypoglycemiaActive, not recruitingNCT06747468Phase 3
• A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in NondiabeticsCompletedNCT04466566Phase 3
• The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2DCompletedNCT03246451Not applicable
• Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small IntestinesCompletedNCT03241303Not applicable
• Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric HypoglycemiaCompletedNCT02996812Phase 1
• Glucagon Like Peptide-1 in Remote Ischemic ConditioningCompletedNCT02746757Not applicable
• Role of GLP-1 in Hyperinsulinemic Hypoglycemia Post-bariatric SurgeryTerminatedNCT02550145Phase 1
• Influence of Gut Hormones on Food Intake After Roux-en-Y Gastric Bypass SurgeryCompletedNCT02336659Not applicable
• A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food IntakeCompletedNCT02128581Phase 1
• Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in HumansCompletedNCT01900340Phase 1
• Incretin Regulation of Insulin Secretion in Monogenic DiabetesCompletedNCT01795144Phase 1
• Ghrelin Effect on Beta Cell Function in Health and DiseaseStatus unknownNCT01729299Not applicable
• The Role of GLP-1 in Satiety Perception in HumansWithdrawnNCT01152333Not applicable
• GLP-1 - Regulatory Mechanism of Postprandial GlycemiaCompletedNCT00980083Phase 1
• Effects of Exendin(9-39) on Gastroduodenal MotilityCompletedNCT00468091Phase 1

← Avexitide overview